Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. [electronic resource]
Producer: 20070117Description: 3997-4002 p. digitalISSN:- 0006-4971
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Body Mass Index
- Child
- Child, Preschool
- Cytarabine -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Infant
- Male
- Mercaptopurine -- administration & dosage
- Methotrexate -- administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Predictive Value of Tests
- Remission Induction
- Retrospective Studies
- Teniposide -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.